HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.

AbstractPURPOSE:
The purpose of this work was to define the optimal margins for gadolinium-enhanced T(1)-weighted magnetic resonance imaging (Gd-MRI) and T(2)-weighted MRI (T(2)-MRI) for delineating target volumes in planning radiation therapy for postoperative patients with newly diagnosed glioblastoma multiforme (GBM) by comparison to carbon-11-labeled methionine positron emission tomography ([(11)C]MET-PET) findings.
METHODS AND MATERIALS:
Computed tomography (CT), MRI, and [(11)C]MET-PET were separately performed for radiation therapy planning for 32 patients newly diagnosed with GBM within 2 weeks after undergoing surgery. The extent of Gd-MRI (Gd-enhanced clinical target volume [CTV-Gd]) uptake and that of T(2)-MRI of the CTV (CTV-T(2)) were compared with the extent of [(11)C]MET-PET (CTV--[(11)C]MET-PET) uptake by using CT--MRI or CT--[(11)C]MET-PET fusion imaging. We defined CTV-Gd (x mm) and CTV-T(2) (x mm) as the x-mm margins (where x = 0, 2, 5, 10, and 20 mm) outside the CTV-Gd and the CTV-T(2), respectively. We evaluated the relationship between CTV-Gd (x mm) and CTV-- [(11)C]MET-PET and the relationship between CTV-T(2) (x mm) and CTV-- [(11)C]MET-PET.
RESULTS:
The sensitivity of CTV-Gd (20 mm) (86.4%) was significantly higher than that of the other CTV-Gd. The sensitivity of CTV-T(2) (20 mm) (96.4%) was significantly higher than that of the other CTV-T(2) (x = 0, 2, 5, 10 mm). The highest sensitivity and lowest specificity was found with CTV-T(2) (x = 20 mm).
CONCLUSIONS:
It is necessary to use a margin of at least 2 cm for CTV-T(2) for the initial target planning of radiation therapy. However, there is a limit to this setting in defining the optimal margin for Gd-MRI and T(2)-MRI for the precise delineation of target volumes in radiation therapy planning for postoperative patients with GBM.
AuthorsMasayuki Matsuo, Kazuhiro Miwa, Osamu Tanaka, Jun Shinoda, Hironori Nishibori, Yusuke Tsuge, Hirohito Yano, Toru Iwama, Shinya Hayashi, Hiroaki Hoshi, Jitsuhiro Yamada, Masayuki Kanematsu, Hidefumi Aoyama
JournalInternational journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 82 Issue 1 Pg. 83-9 (Jan 01 2012) ISSN: 1879-355X [Electronic] United States
PMID21095072 (Publication Type: Comparative Study, Evaluation Study, Journal Article)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Contrast Media
  • Radiopharmaceuticals
  • carbon-11 methionine
  • Methionine
  • Gadolinium
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Neoplasms (diagnostic imaging, pathology, radiotherapy)
  • Contrast Media
  • Female
  • Gadolinium
  • Glioblastoma (diagnostic imaging, pathology, radiotherapy)
  • Humans
  • Magnetic Resonance Imaging (methods)
  • Male
  • Methionine
  • Middle Aged
  • Positron-Emission Tomography (methods)
  • Radiopharmaceuticals
  • Radiotherapy Planning, Computer-Assisted (methods)
  • Sensitivity and Specificity
  • Tomography, Spiral Computed (methods)
  • Tumor Burden
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: